Saint-Petersburg Research Institute of Emergency Medicine named after I.I.Dzhanelidze, St. Petersburg, Russian Federation, 192242, Saint Petersburg
Brief summary
This review analyzes conservative and surgical methods of treating pelvic organ prolapse in elderly women.
An analysis of the literature has shown that the conservative methods of treatment of pelvic organ prolapse presented in the article are used mainly in elderly women with extragenital pathology. And it was noted that it is better to use in the early stages of the disease (grade 2-3).
However, it is worth noting an important aspect: conservative methods do not eliminate the main anatomical cause of the disease - the weakness of the supporting tissues and ligaments of the pelvic floor. Therefore, surgical methods for the treatment of genital prolapse are, in our opinion, optimal for stage III-IV of the disease. These patients prefer small operations, short-term anesthesia, special postoperative management and rehabilitation, described in this article.
Thus, the choice between conservative and surgical treatment should be based on the stage of the disease, the age of the patient, the presence of concomitant diseases and the degree of the patient's commitment to long-term treatment. The surgical approach is preferred in the elderly, as it eliminates the underlying anatomical problem and provides a more reliable and long-term result.
Key words
cystocele; rectocele; colpocleiasis; median colporraphy; pessary; bandage; local hormone therapy
1.Atlas anatomii cheloveka. Frenk Netter; per. s angl. pod red. L.L. Kolesnikova. -6-e izd. -M.; GEOTAR-Media. 2018:340-357
2.Bahaev V.V. Vipadenie polovih organov y jenshin: etiologiya i patogenez. Akysherstvo i ginekologiya. 2009;3:7-10
3.Korshynov M.U., Sergeeva I.V. Ydovletvorennost hiryrgicheskim lecheniem y jenshin s prolapsom tazovih organov: kvantifikaciya i analiz. Jyrnal akysherstva i jenskih boleznei. 2018;67(6):31-37
4.Radzinskii V.E., Maiskova I.U., Dimitrova V.I., Semyatov S.M., Kychieva Z.R. Differencirovannii podhod k hiryrgicheskoi korrekcii prolapsa genitalii y jenshin starshe 60 let. Akysherstvo i Ginekologiya 2012;(4-2):73-7.
5. Syrminov E.I., Novikov E.I. Pokazateli kachestva jizni y jenshin po povody prolapsa genitalii. Materiali konferencii perinatalnaya medicina. SPb. 2025g.
6.Fedorova A. A., Korotkih I. N., Latteva T. N. MaillardC., RubodC., NisolleM., CossonM., FoidartJ.Taktika vedeniya pacientov s prolapsov genitalii. Interaktivnayanayka. 2017;2(12):78-80.
7.Adjoussou S.A, Bohoussou E., Bastide S.,Letouzey V., Fatton B., de Tayrac R. Functional symptoms and associations of women with genital prolapse. Prog Urol. 2014;24(8):511-17. DOI: 10.1016/j.purol.2013.11.015.
8.Giri A., Hartmann K. E., Hellwege J. N., Edwards D. R. V., Edwards T. L. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. American Journal of Obstetrics and Gynecology. 2017;217(1):11-26.
12.IglesiacB, Smithling Kr. Pelvic organ prolapse. American Family Physician.2017;96(3):179-85.
13.Minkin K. V., Jykova O. V., Hamzina I. N. Konservativnoe lechenie prolapsa tazovih organov y jenshin starshei vozrastnoi gryppi. Rossiiskii vestnik akyshera-ginekologa. 2020;20(3):34-40.
15Gould M. K., Garcia D. A., Wren S. M. Prevention of VTE in nonorthopedic surgical patients: antitrombotic therapy and prevention of trombosis, 9 thed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141 (2): e227s-e277s.
16.IglesiacB, Smithling Kr. Pelvic organ prolapse. American Family Physician. 2017;96(3):165-85.
24. Korshynov M.U., Sergeeva I.V, Sazikina E.I., Kyzmin I.V. Effektivnost primeneniya prolenovoi setki y bolnih s prolapsom perednei stenki vlagalisha: randomizirovannoe kontroliryemoe issledovanie. Akysherstvo i ginekologiya. 2004;6:42-46.
25. Krasnopolskii V. I., Byyanova S. N. Opysheniya i vipadeniya vlagalisha i matki. Zabolevaniya sheiki matki, vlagalisha i vylvi / red. V. N. Prilepskaya. M: MEDpressinform. 2003:367-396.
26. Popov A.A. i dr. Hiryrgicheskoe lechenie oslojnennih i neoslojnennih form prolapsa genitalii. Mater. IIZs. Foryma «Mat i ditya». 2000:39—41.
27. Radzinskii V.E., Shalaev O.N., dr. Sakrospinalnayakolpopeksiya kak profilaktika i lechenie prolapsa genitalii vlagalishnim dostypom. Mater. IV Ros. Foryma «Mat i ditya». 2002;2:323—324.
28. Hodjaev G.G. Lechenie recidivov opysheniya i vipadeniya vnytrennih polovih organov y jenshin: Avtoref. diss. 2003.
29. Bump R.C., Norton P.A. Epidemiology and natural history of pelvic floor dysfunction. Obstet. Gynaex. Clin.North.Amer. 1998;25(4):723—746.
31. Radzinskii V.E., Dyrandin U.A., Toktar L.R., i dr. Perineologiya. M.: MIA, 2006:320.
32. Semenuk A.A., Bitukov N.N., Pospelov I.V. Lechenie bolnih s yrogenitalnim prolapsom i nederjaniem mochi. Yrologiya. 2006;1:61-64.
33. Kylakov V. I. Adamyan L.V., Minbaev O.A [i dr.] Hiryrgicheskoe lechenie opysheniya i vipadeniya vlagalisha i matki. Operativnaya ginekologiya. 2000: 741-760.
34. Brown J.S., Waetjen L.E., Subak L.L. et al. Pelvic organ prolapse surgery in the United States, 1997. Am. J. Obstet. Gynecol. 2002;186:712-716.14.
35. Hale D. S., Fenner D. Consistently inconsistent, the posterior vaginal wall. American Journal of Obstetrics and Gynecology. 2016;214(3):314-320.
36. Holbrook A., Schulman S., Witt D. M. Evidence-based management of anticoagulant therapy: antitrombotic therapy and prevention of trombosis, 9 thed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012; 141 (2): e152s-e184s.
37. Kamoeva S. V., Savchenko T. N., Ivanova A. V., Abaeva H. A. Sovremennie geneticheskie aspekti prolapsa tazovih organov y jenshin. Akysherstvo, ginekologiya i reprodykciya. 2013;7(1):17−21.
37. Typikina N.V., Kasyan G.R., Gvozdev M.U.,Barinova M.N., Pyshkar D.U. Nederjanie mochi pri napryajenii posle hiryrgicheskogo lecheniya prolapsa tazovih organov. Eksperimentalnaya i klinicheskaya yrologiya. 2014; 2:82−87.
39.Bo K., Hilde G., Stær-Jensen J. et al. Postpartum pelvic floor muscle training and pelvic organ prolapse: a randomized controlled trial. Obstetrics and Gynecology. 2015;125(3):537-543.
40.Collins S, Lewicky-Gaupp C. Pelvic Organ Prolapse GastroenterolClin North Am. 2022;51(1):177-193.
41.Bezmenko A.A., Berlev I.V. Etiologiya i patogenez genitalnogo prolapsa. Jyrnal akysherstva i jenskih boleznei. 2011;LX(1):129−138.
43. Pyshkar D. U., Gymin L. M. Tazovie rasstroistva y jenshin. M.: MED press-inform. 2006
44. Radzinskii V.E., Shalaev O.N. i dr.//Opit rekonstrykcii tazovogo dna pri prolapse tazovih organov s ispolzovaniem sistemi Prolift®. Vestn. Rossiiskogo yniversiteta dryjbi narodov. —Seriya medicina (akysh. i ginek.). 2007;5:267—270.7. 65.
45. Aleksandrov A. Mesh-less laparoscopic treatment of apical prolapse / A. Aleksandrov, A. V. Smith, B. Rabischong, R. Botchorishvili. Facts, Views & Vision. - 2021;13(2):179-181.
46. Fatton B., de Tayrac R., Letouzey V., Huberlant S. Pelvic organ prolapse and sexual function. Nat. Rev. Urol. 2020; 17 (7): 373-390.
47.Hagen S., Stark D., Glazener C. M., Dickson S., Barry S. J. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomized controlled trial. Lancet. 2014;383:796-806.
48. Ailamazyan E.K. Algoritmi diagnostiki i hiryrgicheskogo lecheniya bolnih s nederjaniem mochi. Akysherstvo i ginekologiya. 2007:34-39
49. Rossiiskie klinicheskie rekomendacii po diagnostike, lecheniu i profilaktike venoznih tromboembolicheskih oslojnenii. M.: Izdatelstvo Media Sfera. 2015:56.
50. Saveleva G.M., Kyrbatskaya E.V., Vlasova M.U. Prolaps tazovih organov y jenshin: sovremennie aspekti diagnostiki i lecheniya. Akysherstvo i ginekologiya. 2018;4: 45-51.
60.Shkarypa D.D. Kratkie metodicheskie rekomendacii po rekonstrykcii tazovogo dna s primeneniem sinteticheskih materialov. Severo-Zapadniĭ centr pelvioperineologii, 2016.
61.Bratzler D. W. Underase of venousthromboembolismprophilaxis for general surgery patients: physician practicesin the community hospital setting. Arch. Intern. Med. l998;158:1909-1912.
62.Adamyan L.V. Sovremennie koncepcii hiryrgicheskogo lecheniya opysheniya i vipadeniya jenskih polovih organov. L.V.Adamyan, M.A. Blinova, B.E. Sashin // Endoskopiya v diagnostike, lechenii i monitoringe jenskih boleznei: Materiali Mejdynarodnogo kongressa. 2000:622-635.
63.Radzinskii V.E. Perinatologiya: bolezni jenskoi promejnosti v akyshersko-ginekologicheskih, seksologicheskih, yrologicheskih, proktologicheskih aspektah. Moskva: OOO «Medicinskoe informacionnoe agentstvo», 2006:336.
64.Carley M.E., Turner R.J., Scott D.E., Alexander J.M. Obstetric history in women with surgically corrected adult urinary incontinence or pelvic organ prolapse. J.Am.Assoc. Gynecol.Laparosc. 1999;6(N.I):85-89.
65.Flebit i tromboflebit poverhnostnih sosydov. Klinicheskie rekomendacii. Moskva,2021:58.
66.Bejenar V. F., Klecel A. Novie algoritmi primeneniya sinteticheskih materialov v hiryrgii tazovogo dna. J.akysh. i jen.bol. 2006:71-72.
67.Strijakova M.A. Sovremennie podhodi k diagnostike i hiryrgicheskomy lecheniu opysheniya jenskih polovih organov.dis. ... d-ra med. nayk. 2001:28.
69.Le Gal G, Righini M, Roy P.M., Sanchez O, et al Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006;144 (3);165-71.
70.Kakkar V.V., Balibrea J.L., Martínez-González J. Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. JournalofThrombosisandHaemostasis, 2010; 8:1223-9.
71.Rodionova T. I. Prolaps organov malogo taza y jenshin pojilogo vozrasta: taktika vedeniya. Akysherstvo i ginekologiya. 2021;10:68-73.
72.Afanasova E.P. Rekonstryktivno-plasticheskie operacii na tazovom dne pri prolapse genitalii. avtoref. diss. ... kand. med.nayk: 2011:19.
73.Fleischer K, Thiagamoorthy G. Pelvic organ prolapse management. PostReproductiveHealth. 2020;26(2):79-85.
78.Plehanov A.N., Bejenar V.F., Bejenar F.V., Epifanova T.A. Preimyshestva primeneniya modificirovannoi operacii kolpokleizisa y pacientok s atipichnimi formami prolapsa tazovih organov. Jyrnal akysherstva i jenskih boleznei. 2024;73(6):142-150.
79. Polyanin D.F., Lykach A.A., Britan M.S., Olhovikova S.V. Reshenie problemi tazovogo prolapsa pri pomoshi sistemi Prosima. Jyrnal akysherstva i jenskih boleznei. 2011:67.
80.Radzinskii V.E.ShalaevO.N.Plaksina N.D. i dr.Pervii klinicheskii opit ispolzovaniya sistemi PROLIFT dlya rekonstrykcii tazovogo dna pri hiryrgicheskom lechenii opysheniya i vipadeniya vnytrennih polovih organov. Akysherstvo i ginekologiya. 2007; 2: 61-66).
81.Styrov N.V. Ispolzovanie bemiparina v kachestve sredstva profilaktiki venoznih trombozov v obshei hiryrgii i operativnoi onkologii. Trydnii pacient. 2012;12(10):16-20.
82.Tarabrin O.A., Tyrenko A.V., Sherbakov S.S. Ispolzovanie bemiparina v kompleksnoi profilaktike i korrekcii naryshenii gemokoagylyacii y bolnih rakom tela matki na etapah hiryrgicheskogo lecheniya. Zdorove jenshini. 2010;4 (50):130-133.
84.Gutman R, Maher C. Uterine-preserving POP. IntUrogynecol J.2013;24:1803-13.
85.Lyman G.H. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline.JClinOncol. 2013; 31.
86. Bejenar F.V. Differencialnii podhod k vibory metoda hiryrgicheskogo lecheniya pacientok s redkimi, oslojnennimi i recidiviryushimi formami genitalnogo prolapsa